Valuation: Avinger, Inc.

Market Cap 27.07L 23.81L 22.51L 20.42L 38.35L 26Cr 38.57L 2.7Cr 1.04Cr 13Cr 1.02Cr 99.43L 43Cr P/E 2022
-0.25x
P/E 2023 -0.19x
Enterprise Value 1.28Cr 1.13Cr 1.07Cr 96.76L 1.82Cr 123.13Cr 1.83Cr 13Cr 4.93Cr 63Cr 4.82Cr 4.71Cr 201.9Cr EV / Sales 2022
1.19x
EV / Sales 2023 1.78x
Free-Float
88.44%
Yield 2022 *
-
Yield 2023 -
3 years 0.36
Extreme 0.363
6.55
5 years 0.36
Extreme 0.363
288.9
10 years 0.36
Extreme 0.363
6,18,002.47
Manager TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer - 05/08/2024
Date Insider Type Main position Quantity % Market Cap. Importance
23/01/25 Sell

Founder

2,215 0.0669%
23/01/25 Sell

Chief Financial Officer

1,255 0.0379%
23/01/25 Sell

Chief Executive Officer

3,690 0.1115%
Change 5-day change 1-year change 3-year change Capi.($)
-20.74%-.--%-.--%-92.77% 15.15L
+3.39%+3.22%-26.64%+1.72% 1.29TCr
-4.64%-5.43%+4.69%-4.86% 396.48Cr
+0.16%-2.03%-43.25%-60.45% 121.38Cr
+1.05%+5.09%+23.32%+92.36% 110.81Cr
-0.67%-0.67%-41.23%-43.51% 108.73Cr
-0.49%-0.56%-34.82% - 102.71Cr
-3.21%-3.06% - - 96Cr
-6.72%-9.32%+20.89%+79.75% 46Cr
+4.06%+11.79%+51.09% - 35Cr
Average -2.78%+1.98%-5.10%-3.97% 230.64Cr
Weighted average by Cap. +0.89%+0.81%-18.31%+1.02%

Financials

2022 2023
Net sales 82.73L 72.76L 68.8L 62.41L 1.17Cr 79Cr 1.18Cr 8.24Cr 3.18Cr 41Cr 3.11Cr 3.04Cr 130.22Cr 76.52L 67.3L 63.64L 57.72L 1.08Cr 73Cr 1.09Cr 7.62Cr 2.94Cr 37Cr 2.87Cr 2.81Cr 120.44Cr
Net income -1.76Cr -1.55Cr -1.47Cr -1.33Cr -2.5Cr -169.17Cr -2.51Cr -18Cr -6.78Cr -86Cr -6.62Cr -6.47Cr -277.39Cr -1.83Cr -1.61Cr -1.52Cr -1.38Cr -2.6Cr -175.86Cr -2.61Cr -18Cr -7.05Cr -90Cr -6.88Cr -6.73Cr -288.36Cr
Net Debt 17.56L 15.44L 14.6L 13.25L 24.88L 17Cr 25.02L 1.75Cr 67.53L 8.6Cr 65.93L 64.5L 28Cr 1.01Cr 89.01L 84.17L 76.34L 1.43Cr 97Cr 1.44Cr 10Cr 3.89Cr 50Cr 3.8Cr 3.72Cr 159.29Cr
Logo Avinger, Inc.
Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.
Employees
70
  1. Stock Market
  2. Stocks
  3. AVGR Stock